Europe – The Future of Europe’s Medical Technology Regulations

MedTech Europe and its members fully support the objectives of the medical technology regulations, In Vitro Diagnostic Medical Devices Regulation 2017/746/EU (IVDR) and Medical...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – Notified Bodies Survey on certifications and applications (MDR/IVDR)

To support monitoring and analyzing the availability of medical devices on the EU market in the context of the implementation of medical devices and in...

New Zealand – Guideline on the Regulation of Therapeutic Products in New Zealand

Pharmacovigilance is defined by the WHO as the science and activities relating to the detection, assessment, understanding and prevention of adverse events or any medicinerelated...

USA – FDA Clears First COVID-19 Home Antigen Test

Today, the U.S. Food and Drug Administration cleared for marketing the first over-the-counter (OTC) antigen test for COVID-19. ACON Laboratories’ Flowflex COVID-19 Antigen Home...
FDA Warns of Cybersecurity Vulnerabilities in Pacemakers, Blood Glucose Monitors

USA – FDA recognizes three new international medical device software security standards

The US Food and Drug Administration (FDA) has recognized three new standards related to software security on medical devices. The standards address taking a...
DEKRA accredited under the MDR

Europe – Un nouveau organisme notifié au titre du règlement (UE) 2017/746

Un nouveau organisme notifié au titre du règlement (UE) 2017/746

Europe – 40ème organisme notifié au titre du règlement (UE) 2017/745

40ème ON notifié au titre du règlement 2017/745

USA – FDA reiterates guidance plans on distributed and point-of-care manufacturing

The US Food and Drug Administration (FDA) this week reiterated its plan to issue draft guidance spelling out how it intends to regulate distributed...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Notified body perspective: Evaluating uses for real-world data

Real-world data (RWD) can provide useful information that may be included in clinical data submissions, but the greatest value may be during the postmarket...

USA – FDA extends regulatory flexibilities for PMA, HDE modifications

The US Food and Drug Administration (FDA) has published a final guidance that extends its pandemic-era policy of allowing manufacturers to make certain modifications...

NOS PROCHAINES FORMATIONS